Literature DB >> 16175390

Effects of geometric isomerism in dinuclear platinum antitumor complexes on aquation reactions in the presence of perchlorate, acetate and phosphate.

Junyong Zhang1, Donald S Thomas, Murray S Davies, Susan J Berners-Price, Nicholas Farrell.   

Abstract

The aquation and subsequent reactions of the dinuclear Pt antitumor complexes [{trans-PtCl(NH(3))(2)}(2)(mu-NH(2)(CH(2))(6)NH(2))](2+) (1,1/t,t) and [{cis-PtCl(NH(3))(2)}(2)(mu-NH(2)(CH(2))(6)NH(2))](2+) (1,1/c,c) in 15 mM perchlorate, acetate or phosphate solutions were followed at 298 K by [(1)H,(15)N] HSQC 2D NMR spectroscopy. Rate and equilibrium constants for the initial reversible aquation and the subsequent reversible reaction with phosphate or acetate are reported. The rate constant for the first aquation step is two-fold lower for 1,1/c,c than 1,1/t,t but the anation rate constants are similar so that the equilibrium lies further towards the chloro form for the 1,1/c,c compound. A pK (a) value of 6.01+/-0.03 was determined for the diaquated species [{cis-Pt(NH(3))(2)(H(2)O)}(2)(mu-NH(2)(CH(2))(6)NH(2))](4+) (1,1/c,c-3) which is 0.4 units higher than that of the 1,1/t,t compound. The rate constants for the binding of acetate and phosphate to 1,1/t,t are similar, but the rate constant for the reverse reaction is close to ten-fold higher in the case of phosphate so that equilibrium conditions are attained more rapidly (12 h compared with 64 h). On the other hand, for 1,1/c,c the rate constants for the forward and reverse reactions with acetate and phosphate are quite similar so that equilibrium conditions are reached very slowly (80-100 h) and a greater proportion of phosphate-bound species are present. The reduced lability of the bound phosphate for 1,1/c,c is attributed to the formation of a macrochelate phosphate-bridged species which was characterized by (31)P NMR and ESI-MS. The speciation profiles of 1,1/t,t and 1,1/c,c under physiological conditions are explored.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175390     DOI: 10.1007/s00775-005-0013-5

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  25 in total

1.  Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464.

Authors:  J Zehnulova; J Kasparkova; N Farrell; V Brabec
Journal:  J Biol Chem       Date:  2001-04-12       Impact factor: 5.157

2.  Controlling the Lability of Square-Planar Pt(II) Complexes through Electronic Communication between pi-Acceptor Ligands This work was supported by the Deutsche Forschungsgemeinschaft, Fonds der Chemischen Industrie, and the Alexander von Humboldt Foundation (fellowship to D.J.).

Authors:  Deogratius Jaganyi; Andreas Hofmann; Rudi van Eldik
Journal:  Angew Chem Int Ed Engl       Date:  2001-05-04       Impact factor: 15.336

3.  A novel trinuclear platinum complex overcomes cisplatin resistance in an osteosarcoma cell system.

Authors:  P Perego; C Caserini; L Gatti; N Carenini; S Romanelli; R Supino; D Colangelo; I Viano; R Leone; S Spinelli; G Pezzoni; C Manzotti; N Farrell; F Zunino
Journal:  Mol Pharmacol       Date:  1999-03       Impact factor: 4.436

4.  Kinetic Analysis of the Reactions between GG-Containing Oligonucleotides and Platinum Complexes. 1. Reactions of Single-Stranded Oligonucleotides with cis-[Pt(NH(3))(2)(H(2)O)(2)](2+) and [Pt(NH(3))(3)(H(2)O)](2+).

Authors:  Florence Gonnet; Franziska Reeder; Jirí Kozelka; Jean-Claude Chottard
Journal:  Inorg Chem       Date:  1996-03-13       Impact factor: 5.165

5.  Slowing of cisplatin aquation in the presence of DNA but not in the presence of phosphate: improved understanding of sequence selectivity and the roles of monoaquated and diaquated species in the binding of cisplatin to DNA.

Authors:  M S Davies; S J Berners-Price; T W Hambley
Journal:  Inorg Chem       Date:  2000-12-11       Impact factor: 5.165

6.  Kinetic analysis of the stepwise formation of a long-range DNA interstrand cross-link by a dinuclear platinum antitumor complex: evidence for aquated intermediates and formation of both kinetically and thermodynamically controlled conformers.

Authors:  J W Cox; S J Berners-Price; M S Davies; Y Qu; N Farrell
Journal:  J Am Chem Soc       Date:  2001-02-21       Impact factor: 15.419

7.  DNA modifications by a novel bifunctional trinuclear platinum phase I anticancer agent.

Authors:  V Brabec; J Kaspárková; O Vrána; O Nováková; J W Cox; Y Qu; N Farrell
Journal:  Biochemistry       Date:  1999-05-25       Impact factor: 3.162

8.  Kinetic and equilibria studies of the aquation of the trinuclear platinum phase II anticancer agent [(trans-PtCl(NH(3))(2))(2)(mu-trans-Pt(NH(3))(2)(NH(2)(CH(2))(6)NH(2))(2))](4+) (BBR3464).

Authors:  Murray S Davies; Donald S Thomas; Alexander Hegmans; Susan J Berners-Price; Nicholas Farrell
Journal:  Inorg Chem       Date:  2002-03-11       Impact factor: 5.165

9.  Long range 1,4 and 1,6-interstrand cross-links formed by a trinuclear platinum complex. Minor groove preassociation affects kinetics and mechanism of cross-link formation as well as adduct structure.

Authors:  Alexander Hegmans; Susan J Berners-Price; Murray S Davies; Donald S Thomas; Anthony S Humphreys; Nicholas Farrell
Journal:  J Am Chem Soc       Date:  2004-02-25       Impact factor: 15.419

10.  Effect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II).

Authors:  M Jennerwein; P A Andrews
Journal:  Drug Metab Dispos       Date:  1995-02       Impact factor: 3.922

View more
  9 in total

1.  The trans influence in the modulation of platinum anticancer agent biology: the effect of nitrite leaving group on aquation, reactions with S-nucleophiles and DNA binding of dinuclear and trinuclear compounds.

Authors:  Eva I Montero; Junyong Zhang; Joseph J Moniodis; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chemistry       Date:  2010-08-09       Impact factor: 5.236

2.  Effects of geometric isomerism and anions on the kinetics and mechanism of the stepwise formation of long-range DNA interstrand cross-links by dinuclear platinum antitumor complexes.

Authors:  Junyong Zhang; Donald S Thomas; Susan J Berners-Price; Nicholas Farrell
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

3.  Influence of geometric isomerism on the binding of platinum anticancer agents with phospholipids.

Authors:  Anil K Gorle; Junyong Zhang; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2019-07-02       Impact factor: 4.390

4.  Solution studies of dinuclear polyamine-linked platinum-based antitumour complexes.

Authors:  Rasha A Ruhayel; Ibrahim Zgani; Susan J Berners-Price; Nicholas P Farrell
Journal:  Dalton Trans       Date:  2011-03-08       Impact factor: 4.390

5.  Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism.

Authors:  Brad T Benedetti; Erica J Peterson; Peyman Kabolizadeh; Alberto Martínez; Ralph Kipping; Nicholas P Farrell
Journal:  Mol Pharm       Date:  2011-05-16       Impact factor: 4.939

6.  Determination of the kinetic profile of a dinuclear platinum anticancer complex in the presence of sulfate: introducing a new tool for the expedited analysis of 2D [(1)H,( 15)N] HSQC NMR spectra.

Authors:  Rasha A Ruhayel; Ben Corry; Carlos Braun; Donald S Thomas; Susan J Berners-Price; Nicholas P Farrell
Journal:  Inorg Chem       Date:  2010-11-10       Impact factor: 5.165

7.  A dinuclear monofunctional platinum(II) complex with an aromatic linker shows low reactivity towards glutathione but high DNA binding ability and antitumor activity.

Authors:  Damin Fan; Xiaoliang Yang; Xiaoyong Wang; Shouchun Zhang; Jiafei Mao; Jian Ding; Liping Lin; Zijian Guo
Journal:  J Biol Inorg Chem       Date:  2007-03-03       Impact factor: 3.862

8.  Antiangiogenic platinum through glycan targeting.

Authors:  Erica J Peterson; A Gerard Daniel; Samantha J Katner; Lisa Bohlmann; Chih-Wei Chang; Anna Bezos; Christopher R Parish; Mark von Itzstein; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Sci       Date:  2016-08-12       Impact factor: 9.825

9.  1H and 195Pt NMR prediction for inclusion compounds formed by cisplatin and oxidized carbon nanostructures.

Authors:  Leonardo A De Souza; Eduardo R Almeida; Joyce H Cunha E Silva; Diego F S Paschoal; Jadson C Belchior; Hélio F Dos Santos; Wagner B De Almeida
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 3.361

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.